Key statistics
On Friday, Aldeyra Therapeutics Inc (137:FRA) closed at 5.35, -14.95% below its 52-week high of 6.30, set on Oct 02, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 5.35 |
---|---|
High | 5.35 |
Low | 5.35 |
Bid | 5.23 |
Offer | 5.33 |
Previous close | 5.25 |
Average volume | 1.64k |
---|---|
Shares outstanding | 59.42m |
Free float | 48.69m |
P/E (TTM) | -- |
Market cap | 349.99m USD |
EPS (TTM) | -0.6387 USD |
Data delayed at least 15 minutes, as of Sep 20 2024 07:20 BST.
More ▼
Press releases
- Aldeyra Therapeutics to Participate in the H.C. Wainwright 26th Annual Global Investment Conference
- Aldeyra Therapeutics Achieves Primary Endpoint in Phase 3 Dry Eye Disease Clinical Trial of Reproxalap
- Aldeyra Therapeutics Schedules Conference Call and Webcast to Announce Top-Line Results from the Phase 3 Dry Eye Chamber Clinical Trial of Reproxalap